Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery.